Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle

被引:70
作者
Blaauw, Bert [1 ,2 ]
Mammucari, Cristina [1 ,2 ]
Toniolo, Luana [3 ]
Agatea, Lisa [1 ,2 ]
Abraham, Reimar [1 ]
Sandri, Marco [1 ,2 ,4 ]
Reggiani, Carlo [3 ]
Schiaffino, Stefano [1 ,2 ]
机构
[1] VIMM, I-35126 Padua, Italy
[2] Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, Padua, Italy
[3] Univ Padua, Dept Human Anat & Physiol, Padua, Italy
[4] Dulbecco Telethon Inst, Modena, Italy
关键词
D O I
10.1093/hmg/ddn264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Skeletal muscles of the mdx mouse, a model of Duchenne Muscular Dystrophy, show an excessive reduction in the maximal tetanic force following eccentric contractions. This specific sign of the susceptibility of dystrophin-deficient muscles to mechanical stress can be used as a quantitative test to measure the efficacy of therapeutic interventions. Using inducible transgenesis in mice, we show that when Akt activity is increased the force drop induced by eccentric contractions in mdx mice becomes similar to that of wild-type mice. This effect is not correlated with muscle hypertrophy and is not blocked by rapamycin treatment. The force drop induced by eccentric contractions is similar in skinned muscle fibers from mdx and Akt-mdx mice when stretch is applied directly to skinned fibers. However, skinned fibers isolated from mdx muscles exposed to eccentric contractions in vivo develop less isometric force than wild-type fibers and this force depression is completely prevented by Akt activation. These experiments indicate that the myofibrillar-cytoskeletal system of dystrophin-deficient muscle is highly susceptible to a damage caused by eccentric contraction when elongation is applied in vivo, and this damage can be prevented by Akt activation. Microarray and PCR analyses indicate that Akt activation induces up-regulation of genes coding for proteins associated with Z-disks and costameres, and for proteins with anti-oxidant or chaperone function. The protein levels of utrophin and dysferlin are also increased by Akt activation.
引用
收藏
页码:3686 / 3696
页数:11
相关论文
共 62 条
  • [1] Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery
    Abmayr, S
    Gregorevic, P
    Allen, JM
    Chamberlain, JS
    [J]. MOLECULAR THERAPY, 2005, 12 (03) : 441 - 450
  • [2] Skeletal muscle function: Role of ionic changes in fatigue, damage and disease
    Allen, DG
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (08): : 485 - 493
  • [3] Defective membrane repair in dysferlin-deficient muscular dystrophy
    Bansal, D
    Miyake, K
    Vogel, SS
    Groh, S
    Chen, CC
    Williamson, R
    McNeil, PL
    Campbell, KP
    [J]. NATURE, 2003, 423 (6936) : 168 - 172
  • [4] Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse
    Barash, IA
    Mathew, L
    Ryan, AF
    Chen, J
    Lieber, RL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 286 (02): : C355 - C364
  • [5] Desmin cytoskeletal modifications after a bout of eccentric exercise in the rat
    Barash, IA
    Peters, D
    Fridén, J
    Lutz, GJ
    Lieber, RL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 283 (04) : R958 - R963
  • [6] Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
    Barton, ER
    Morris, L
    Musaro, A
    Rosenthal, N
    Sweeney, HL
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 157 (01) : 137 - 147
  • [7] Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
    Bodine, SC
    Stitt, TN
    Gonzalez, M
    Kline, WO
    Stover, GL
    Bauerlein, R
    Zlotchenko, E
    Scrimgeour, A
    Lawrence, JC
    Glass, DJ
    Yancopoulos, GD
    [J]. NATURE CELL BIOLOGY, 2001, 3 (11) : 1014 - 1019
  • [8] Functional improvement of dystrophic muscle by myostatin blockade
    Bogdanovich, S
    Krag, TOB
    Barton, ER
    Morris, LD
    Whittemore, LA
    Ahima, RS
    Khurana, TS
    [J]. NATURE, 2002, 420 (6914) : 418 - 421
  • [9] Myostatin propeptide-mediated amelioration of dystrophic pathophysiology
    Bogdanovich, S
    Perkins, KJ
    Krag, TOB
    Whittemore, SA
    Khurana, TS
    [J]. FASEB JOURNAL, 2005, 19 (06) : 543 - 549
  • [10] Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins
    Bonuccelli, G
    Sotgia, F
    Schubert, W
    Park, DS
    Frank, PG
    Woodman, SE
    Insabato, L
    Cammer, M
    Minetti, C
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) : 1663 - 1675